GPX4 and diffuse large B-cell lymphoma: This multifaceted disruption sensitizes DLBCL cells to even low concentrations of GPX4 inhibitors, leading to additive cell death that is fully reverted by the lipophilic radical-trapping agent ferrostatin-1.